The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Lai, C; Kandahari, AM; Ujjani, C

Lai, C (reprint author), Medstar Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019; 9 (): 63

Abstract

The arrival of the CD30 directed antibody-drug conjugate, brentuximab vedotin (BV), has altered the approach to patients with classical Hodgkin lympho......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索